Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 24;99(52):e23453.
doi: 10.1097/MD.0000000000023453.

Efficacy and safety of montelukast sodium combined with fluticasone in the treatment of adult bronchial asthma: A protocol for systematic review and meta-analysis

Huiling Luo  1 , Hongmei Han  1 , Xiaoli Liu  1 , Qin Liu  2
Affiliations

Efficacy and safety of montelukast sodium combined with fluticasone in the treatment of adult bronchial asthma: A protocol for systematic review and meta-analysis

Huiling Luo et al. Medicine (Baltimore). .

Abstract

Background: Bronchial asthma (BA) is a chronic airway inflammatory disease with reversible airflow limitation as the main clinical manifestations, such as wheezing, cough, shortness of breath, chest tightness, etc, mediated by a variety of inflammatory cells, which can be recurrent. Clinical can improve symptoms, but cannot be cured; glucocorticoid is the most important first-line medication. Clinical practice has shown that montelukast sodium combined with fluticasone in the treatment of adult BA can improve clinical efficacy and reduce adverse reactions. The purpose of this study is to systematically study the efficacy and safety of montelukast sodium combined with fluticasone in the treatment of adult BA.

Methods: The Chinese databases (CNKI, VIP, Wanfang, Chinese Biomedical Database) and English databases (PubMed, the Cochrane Library, Embase, Web of Science) were searched by computer, for the randomized controlled clinical studies of montelukast sodium combined with fluticasone in the treatment of adult BA from establishment of database to October 2020. Two researchers independently extracted the relevant data and evaluated the quality of the literatures, and used RevMan5.3 software to conduct meta-analyze of the included literatures.

Results: This study assessed the efficacy and safety of montelukast sodium combined with fluticasone in the treatment of adult BA through total effective rate, pulmonary function (FEV1, FVC, PEF, FEV1/FVC), and adverse reactions.

Conclusion: This study will provide reliable evidence-based evidence for the clinical application of montelukast sodium combined with fluticasone in the treatment of adult BA.

Osf registration number: DOI 10.17605/OSF.IO/CKQFM.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
The process of literature filtering.
See this image and copyright information in PMC

References

    1. CRC Press, William S. Lynn Inflammatory Cells & Lung Disease. 2019.
    1. Nosayba AA, Lina E. Leukotriene D role in allergic asthma pathogenesis from cellular and therapeutic perspectives. Life Sci 2020;260:118452. - PubMed
    1. Bhalla Kl, Nehra D, Nanda S, et al. Prevalence of bronchial asthma and its associated risk factors in school-going adolescents in Tier-III North Indian City. J Family Med Prim Care 2018;7:1452–7. - PMC - PubMed
    1. Li ZY, Han WY, Jian FM. Advances in the treatment of acute attack of bronchial asthma with integrated Chinese and western medicine. J Emerg Trad Chinese Med 2016;25:461–3.
    1. Chang YY. Advances in clinical drug research on bronchial asthma based on mechanism of action. Chinese J Geriatr Care 2020;18:103–4.

MeSH terms